Hautveränderungen nach Blockade des Epidermal-growth-factor-Rezeptors
✍ Scribed by E. Bierhoff; H. W. Seifert; T. Dirschka
- Publisher
- Springer
- Year
- 2006
- Tongue
- German
- Weight
- 462 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0172-8113
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The purpose of our research was to investigate the antiangiogenic effect of the epidermal growth factor receptor monoclonal antibody (anti-EGF-R MAB) EMD72000, in an orthotopic human pancreatic carcinoma model in rats, assessed by magnetic resonance (MR) imaging using angiogenic surrogate markers in
## Abstract Inhibiting epidermal growth factor‐receptor (ErbB‐1) represents a powerful anticancer strategy. Activation of retinoid pathways is also in development for cancer treatment. Retinoic acid receptor‐β—the tumor suppressor and main retinoid mediator—‐is silenced in many tumors. The ErbB‐1 i